| NCT ID | NCT04690660 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Postpartum Hypertension (PPHT) |
| Study Type | OBSERVATIONAL |
| Enrollment | 480 participants |
| Start Date | 2020-06-04 |
| Primary Completion | 2030-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 480 participants in total. It began in 2020-06-04 with a primary completion date of 2030-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk. Current disease management strategies will be evaluated.
Eligibility Criteria
Inclusion Criteria: * all women with hypertensive disorders of pregnancy * postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery) * women with preexisting hypertension or * women on antihypertensive medication Exclusion Criteria: * delivery \> 14 days * lack of consent to participate in the study, language barriers or lack of general understanding
Contact & Investigator
Thenral Socrates, Dr. med.
PRINCIPAL INVESTIGATOR
Medical Outpatient Department and Hypertension Clinic, University Hospital BaselUni
Frequently Asked Questions
Who can join the NCT04690660 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum Hypertension (PPHT). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04690660 currently recruiting?
Yes, NCT04690660 is actively recruiting participants. Contact the research team at thenral.socrates@usb.ch for enrollment information.
Where is the NCT04690660 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT04690660 clinical trial?
NCT04690660 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Thenral Socrates, Dr. med. at Medical Outpatient Department and Hypertension Clinic, University Hospital BaselUni. The trial plans to enroll 480 participants.